San Diego, Ca., USA - Organovo Holdings, Inc., a biotechnology company, announced that Tamar D. Howson has been appointed to the company's board of directors.
Article continues below
Ms. Howson was appointed to each of the Board's standing committees, including its audit committee.
Ms. Howson is a seasoned business development executive within the pharmaceutical industry, having formerly served as senior vice president of both Bristol-Meyers Squibb and SmithKline Beecham.
Ms. Howson currently serves as a corporate business development and strategy consultant to biopharmaceutical companies and she also serves as a director at Idenix, Oxigene Pharmaceuticals, and Warner Chilcott.
During 2009 and 2010 she was a member of the transaction advisory firm, JSB Partners.
During 2007 and 2008 she served as senior vice president of Corporate and Business Development at Lexicon, a biotechnology company.
Between 2001 and 2007 Ms. Howson was the senior vice president of Corporate and Business Development at Bristol Myers Squibb, overseeing mergers and acquisitions, licensing, and research collaborations across all business sectors.
Between 1991 and 2000 she was vice president and the senior vice president and director of Worldwide Business and Corporate Development for SmithKline Beecham where she also managed SmithKline Beecham's venture capital fund, SR One.
She has formerly served as a director at several biotechnology companies, including Ariad, NPS Pharmaceuticals, and SkyePharma.
Ms. Howson holds an MBA from Columbia University, a MS from City University of New York, and a BS in Chemical Engineering from the Technion, Israel.
Organovo also announced the resignation of Adam Stern from the Board.
Mr. Stern has more than 25 years of venture capital and investment banking experience focusing primarily on the life science and technology sectors of the capital markets.
Mr. Stern currently is a director at Prolor Biotech, InVivo Therapeutics, Organovo Holdings, and LabStyle Innovations.
Prior to being Head of Private Equity Banking at Aegis Capital and CEO of SternAegis Ventures, Mr. Stern was the Senior Managing Director at Spencer Trask Ventures from 1997 to 2012 and was at Josephthal & Co. from 1989 to 1997 as Senior Vice President and Managing Director of Private Equity Marketing. ■